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The goal of our research is to develop an approach to early
detection and diagnosis of oral neoplasia using optical-
based technologies such as fluorescence spectroscopy and
imaging, high-resolution microendoscopy and molecu-
larly-targeted optical contrast agents. Although patients
with early disease have better chances for cure and func-
tional outcome, most patients present with advanced
tumours when treatment is less successful and often
causes severe deficits in speech, swallowing, facial appear-
ance and quality of life. To improve outcomes we must
improve detection and diagnosis of early neoplastic
changes. Changes in tissue architecture, morphology, and
molecular composition that occur during carcinogenesis
also produce changes in the optical properties of tissue.
These changes can be detected non-invasively, in vivo,
and in near real-time using optical spectroscopy and
imaging. Our research group has developed multi-spectral
imaging devices for wide field visualization of early
changes in oral mucosa. We are investigating whether
these devices can improve the clinician's ability 1) to
improve visualization of early neoplastic changes in oral
mucosa that can be difficult to see using normal white
light examination in community settings, 2) to choose
optimal sites within lesions to perform biopsies, and 3) to
visualize the peripheral margins of disease. We have also
shown that using computer algorithms and disease prob-
ability maps, optical imaging and spectroscopy can pro-
vide objective discrimination between normal and
abnormal oral mucosa with good sensitivity and specifi-
city – similar to that of oral cancer specialists. We are now
developing simplified optical devices to use in screening
and diagnosis in community settings.
In addition, we are evaluating the use of molecularly tar-
geted optical contrast agents for non-invasive diagnosis
and molecular characterization of oral mucosal lesions.
These contrast agents can potentially be used in conjunc-
tion with portable microendoscopes and confocal micro-
scopes that have sufficient resolution to visualize cellular
features in vivo, to provide non-invasive "optical biop-
sies" of suspicious areas.
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